Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products, today announced the ...

Anyone who has ever been on a diet knows there are sensible ways to lose weight, including eating a balanced diet and exercising.

It wasn’t until late last year, 35 years into its history, that Ionis Pharmaceuticals e | To support the launch of Tryngolza, ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

While it was previously more common in older people, changes in diet and rising levels of obesity ... FDA's Center for Drug Evaluation and Research, in the press release. 1. FDA Approves First ...

Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...

Investing.com -- The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use ... blood sugar levels in conjunction with diet and exercise in adults with type 2 diabetes.

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Ionis Pharma's olezarsen has become the first FDA-approved drug therapy for adults with familial ... the Tryngolza brand name as an adjunct to diet to reduce triglycerides in adults with FCS ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. Females ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...